Innovations in cancer immunotherapy: chimeric antigen receptor T-cell therapy (CAR-T)

CMAJ. 2021 Aug 23;193(33):E1300-E1302. doi: 10.1503/cmaj.202907.

¹ Leukemia and Bone Marrow Transplant Program of British Columbia (Hay); Division of Hematology, Department of Medicine (Seftel, Hay), University of British Columbia; Canadian Blood Services (Seftel); Terry Fox Laboratory (Hay), British Columbia Cancer Research Institute, Vancouver, BC; Department of Internal Medicine (Brown), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.
² Leukemia and Bone Marrow Transplant Program of British Columbia (Hay); Division of Hematology, Department of Medicine (Seftel, Hay), University of British Columbia; Canadian Blood Services (Seftel); Terry Fox Laboratory (Hay), British Columbia Cancer Research Institute, Vancouver, BC; Department of Internal Medicine (Brown), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man. khay@bccrc.ca.

No abstract available

Publication types